Bringing science and development together through news and analysis

  • A new way to develop tests for neglected diseases

Shares

Safe, reliable tests to diagnose neglected diseases are as urgently needed as drugs to treat the infections, say Martine Usdin and colleagues of Doctors Without Borders (Médecins Sans Frontières or MSF) in this article in Nature.

In resource-poor settings, tests must be cheap, effective and easy to use in the field, they say.

MSF has developed such a product — a rapid test for malaria — in just two years. It managed this by using published research as a starting point, and then considering the field conditions under which the test would need to work in order to ensure that the final product would be appropriate.

MSF brought together scientists and field clinicians to design the test and then allowed three manufacturers to compete to optimise the test for use and performance. The charity then evaluated the test in field projects, the last of which is now underway.

By speeding up the development process the charity kept costs down and boosted the test's chances of reaching the market; the entire process cost US$100,000, a fraction of the usual price.

The researchers say MSF’s approach could become a new model for developing diagnostic tools for use in resource-poor settings.

Link to full article in Nature

Republish
We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.